Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

Well-fed mothers produce babies with healthy hearts

Prenatal care is vital to the future health of a baby. It’s important for expecting mothers to stop smoking and drinking alcohol and to increase their folic acid intake. But in addition to these steps, mothers must also maintain a healthy weight.

TCT 2016: Sapien valve is durable up to 5 years in patients with severe aortic stenosis

Patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) with the Sapien first generation device had positive hemodynamics up to five years following implant, according to an analysis of a randomized trial.

Thumbnail

TCT 2016: Quality of life at two years is similar for TAVR, SAVR patients

After one month, patients with severe aortic stenosis and intermediate surgical risk had improved health status if they underwent transcatheter aortic valve replacement (TAVR) rather than surgical aortic valve replacement (SAVR), according to an analysis of a randomized study. The analysis also found that patients in both groups had similar quality of life outcomes at two years.

Thumbnail

If You Give a Cardiologist a Crystal Ball

For this issue, we gave cardiologists a crystal ball, figuratively, of course, and asked them what they saw for their specialty’s future.

FDA expands approval for Medtronic’s CoreValve Evolut R system in larger size

The FDA approved Medtronic’s CoreValve Evolut R system in a new 34 mm size valve for patients undergoing transcatheter aortic valve replacement (TAVR).

Thumbnail

Mitral Mysteries: Imagers Explore a New Frontier in Transcatheter Valve Replacement

Transcatheter aortic valve replacement offers valuable lessons that can be applied to its mitral valve counterpart, according to imagers on the frontlines for both techniques.

Thumbnail

Stents + Sensibility: Talking Technology + Trends with Cardiology Device Makers

David J. Cohen, MD, MSc, and the chief medical officers of three stent companies discuss stents, strategy and the future of healthcare.

Thumbnail

Preparing for the Flood: Expanded TAVR Indication Comes with Challenges

SCAI examines the implications of the FDA’s decision to expand the TAVR indication to include patients at intermediate risk for SAVR.

Displaying 1057 - 1064 of 2332

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.